Related Experiment Video
Updated: Jan 21, 2026
05:18
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
5.7K
Extracellular Vesicles in Type 1 Diabetes: Messengers and Regulators
Sarita Negi1,2, Alissa K Rutman1,2, Steven Paraskevas3,4
1Human Islet Transplant Laboratory, Department of Surgery, D5.5736, Royal Victoria Hospital, McGill University Health Centre, 1001 Boulevard Décarie, Montréal, QC, H4A 3J1, Canada.
Current Diabetes Reports
|August 2, 2019
Summary
Extracellular vesicles (EV) link islet inflammation to type 1 diabetes (T1D) autoimmunity. These vesicles, carrying autoantigens, are key to disease development and offer potential as T1D biomarkers and therapies.
Area of Science:
- Immunology
- Endocrinology
- Cell Biology
Background:
- Type 1 diabetes (T1D) pathogenesis theories implicate islet inflammation in initiating autoimmune responses.
- Extracellular vesicles (EV) are emerging as a critical link between inflammation and the development of autoimmunity in T1D.
Purpose of the Study:
- To review the role of EV in the pathogenesis of type 1 diabetes.
- To discuss the potential clinical applications of EV as biomarkers and therapeutic agents for T1D.
Main Methods:
- Review of current scientific literature on EV and T1D.
- Analysis of EV cargo, including autoantigens and miRNAs, using multi-parametric technologies.
Main Results:
- EV derived from beta cells contain diabetogenic autoantigens and miRNAs.
- These EV mediate antigen presentation and cell-to-cell communication, activating autoimmune responses.
- EV show promise as diagnostic biomarkers and therapeutic agents for T1D.
Conclusions:
- EV play a pivotal role in T1D pathogenesis by bridging inflammation and autoimmunity.
- Further analysis of EV cargo can enhance understanding of T1D mechanisms.
- EV represent promising avenues for T1D diagnostics and therapeutics.
Keywords:
AutoimmunityBiomarkersExtracellular vesiclesIslets of LangerhansType 1 diabetesβ-cell injuryMore Related Videos
Related Concept Videos
01:12What are Second Messengers?
90.3K
Because many receptor binding ligands are hydrophilic, they do not cross the cell membrane and thus their message must be relayed to a second messenger on the inside. There are several second messenger pathways, each with their own way of relaying information. G-protein coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol path is active when the receptor induces phospholipase C to hydrolyze the phospholipid,...
90.3K
01:22Diabetes Mellitus: Type 2 and Gestational
4.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.4K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.0K
01:46Epigenetic Regulation
33.5K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K
01:15Amplifying Signals via Second Messengers
8.5K
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
8.5K
01:33Hormonal Regulation
35.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.8K